Cisen Pharmaceutical Co Ltd (603367) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million ≈ $45.64 Million USD) by net assets (CN¥6.19 Billion ≈ $906.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Cisen Pharmaceutical Co Ltd (603367) total market value for the company's overall valuation and market capitalisation.

Cisen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Cisen Pharmaceutical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hunan New Wellful Co Ltd SHG:600975	0.064x
Citic Press Corp SHE:300788	0.070x
Sichuan Lutianhua Co Ltd SHE:000912	0.035x
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS IS:ECILC	0.014x
Carlsberg Brewery Malaysia Bhd KLSE:2836	0.114x
Changyuan Group Ltd SHG:600525	0.048x
FAWER Automotive Parts Ltd Co SHE:000030	0.028x
Beijing Oriental Jicheng Co Ltd SHE:002819	0.017x

Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2025. View Cisen Pharmaceutical Co Ltd (603367) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.23 Billion ≈ $911.75 Million	CN¥466.37 Million ≈ $68.25 Million	0.075x	-21.50%
2024-12-31	CN¥5.99 Billion ≈ $876.08 Million	CN¥570.85 Million ≈ $83.53 Million	0.095x	+21.85%
2023-12-31	CN¥5.77 Billion ≈ $843.81 Million	CN¥451.24 Million ≈ $66.03 Million	0.078x	+62.23%
2022-12-31	CN¥5.36 Billion ≈ $783.73 Million	CN¥258.35 Million ≈ $37.80 Million	0.048x	+4.39%
2021-12-31	CN¥5.06 Billion ≈ $739.79 Million	CN¥233.60 Million ≈ $34.18 Million	0.046x	-48.52%
2020-12-31	CN¥4.80 Billion ≈ $702.68 Million	CN¥431.01 Million ≈ $63.07 Million	0.090x	+126.48%
2019-12-31	CN¥4.57 Billion ≈ $669.29 Million	CN¥181.26 Million ≈ $26.52 Million	0.040x	-59.51%
2018-12-31	CN¥4.15 Billion ≈ $608.01 Million	CN¥406.68 Million ≈ $59.51 Million	0.098x	-17.08%
2017-12-31	CN¥3.72 Billion ≈ $544.98 Million	CN¥439.61 Million ≈ $64.33 Million	0.118x	-7.08%
2016-12-31	CN¥2.30 Billion ≈ $336.34 Million	CN¥291.97 Million ≈ $42.72 Million	0.127x	+0.13%
2015-12-31	CN¥2.10 Billion ≈ $307.11 Million	CN¥266.24 Million ≈ $38.96 Million	0.127x	+775.81%
2014-12-31	CN¥1.90 Billion ≈ $278.19 Million	CN¥27.54 Million ≈ $4.03 Million	0.014x	-69.23%
2013-12-31	CN¥1.73 Billion ≈ $252.63 Million	CN¥81.26 Million ≈ $11.89 Million	0.047x	+125.43%
2012-12-31	CN¥1.58 Billion ≈ $231.88 Million	CN¥33.09 Million ≈ $4.84 Million	0.021x	-63.20%
2011-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥76.28 Million ≈ $11.16 Million	0.057x	--

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$967.28 Million

CN¥6.61 Billion CNY

Market Cap Rank

#9172 Global

#2305 in China

Share Price

CN¥14.60

Change (1 day)

+0.97%

52-Week Range

CN¥12.45 - CN¥24.20

All Time High

CN¥34.05